TheraVet Announces the Appointment of a Chief Financial Officer to Reinforce Its Global Financing and Cost Control Strategy
GOSSELIES, October 25, 2023--Regulatory News: TheraVet (ISIN: BE0974387194 - ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, today announced the appointment of Rodolphe Lebrun as Chief Financial Officer.